Abstract
NF-κB transcription factor plays a vital role in the protection of transformed cells from apoptosis, thus resulting in the onset/progression of cancer. Activation of NF-κB is strictly controlled by IκB kinase, and therefore IκB kinase inhibition forms the basis for anticancer drug research. We present here a novel fragment-based QSAR model using 4-arylidene curcumin analogues having IκB kinase inhibitory properties. The insights into the contribution of each chemical fragment of the analogues in IκB kinase inhibitory activity were used to generate a combinatorial library containing 167,828 molecules and their inhibitory activities were predicted by the reported G-QSAR model. We report top two scoring compounds BEP and BHP possessing high docking scores of −9.21 and −8.98 kcal/mol, respectively. Molecular dynamics simulations studies showed that the trajectories of the IκB kinase complexed with BEP and BHP were stable over a considerably long time period (16 ns). The two compounds reported here showed high binding affinity and stability with IκB kinase and thus can be taken forward as promising anticancer leads. The G-QSAR model reported here will pave way for the development of novel leads by high-throughput activity prediction of similar compounds.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Afantitis A, Melagraki G, Sarimveis H, Igglessi-Markopoulou O, Kollias G (2009) A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas. Eur J Med Chem 44:877–884
Alexander G, Alexander T (2002) Beware of Q2! J Mol Gr Model 20:269–276
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–818
Baldwin AS (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107:241–246
Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dörken B (1997) Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin’s disease tumor cells. J Clin Invest 100:2961
Collins T, Read M, Neish A, Whitley M, Thanos D, Maniatis T (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 9:899–909
Dhanjal JK, Goyal S, Sharma S, Hamid R, Grover A (2013) Mechanistic insights into mode of action of potent natural antagonists of BACE-1 for checking Alzheimer’s plaque pathology. Biochem Bioph Res Co 443:1054–1059
Dhanjal JK, Grover S, Paruthi P, Sharma S, Grover A (2014) Mechanistic insights into mode of action of a potent natural antagonist of orexin receptor-1 by means of high throughput screening and molecular dynamics simulations. Com Chem High TScr 17:124–131
Delhase M, Hayakawa M, Chen Y, Karin M (1999) Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science 284:309–313
Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577–8593
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749
Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177–6196
Golbraikh A, Tropsha A (2002) Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. Mol Divers 5:231–243
Goyal M, Grover S, Dhanjal JK, Goyal S, Tyagi C, Grover A (2013) Molecular modeling studies on flavonoid derivatives as dual site inhibitors of human acetyl cholinesterase using 3D-QSAR, pharmacophore and high throughput screening approaches. Med Chem Res 23:2122–2132
Goyal M, Dhanjal JK, Goyal S, Tyagi C, Hamid R, Grover A (2014a) Development of dual inhibitors against Alzheimer’s disease using fragment-based QSAR and molecular docking. Biomed Res Intl 2014:1–12
Goyal S, Dhanjal JK, Tyagi C, Goyal M, Grover A (2014b) Novel fragment based QSAR modelling and combinatorial design of pyrazole derived CRK3 inhibitors as potent anti-leishmanials. Chem Bio Drug Des 84:54–62
Goyal S, Grover S, Dhanjal JK, Goyal M, Tyagi C, Chacko S, Grover A (2014c) Mechanistic insights into mode of actions of novel oligopeptidase B inhibitors for combating leishmaniasis. J Mol Model 20:2099
Haaland DM, Thomas EV (1988) Partial least-squares methods for spectral analyses. 1. Relation to other quantitative calibration methods and the extraction of qualitative information. Anal Chem 60:1193–1202
Halgren TA (1996) Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J Comput Chem 17:520–552
Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750–1759
Hatcher H, Planalp R, Cho J, Torti FM, Torti SV (2008) Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65:1631–1652
Holmes-McNary M, Baldwin AS (2000) Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase. Cancer Res 60:3477–3483
Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH (1994) Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54:5841–5847
Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118:11225–11236
Kabrun N, Enrietto PJ (1994) The Rel family of proteins in oncogenesis and differentiation. Semin Cancer Biol 5:103–112
Kaminski GA, Friesner RA, Tirado-Rives J, Jorgensen WL (2001) Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J Phys Chem B 105:6474–6487
Leu TH, Maa MC (2002) The molecular mechanisms for the antitumorigenic effect of curcumin. Curr Med Chem Anticancer Agents 2:357–370
Liu S, Misquitta YR, Olland A, Johnson MA, Kelleher KS, Kriz R, Lin LL, Stahl M, Mosyak L (2013) Crystal structure of a human IκB kinase β asymmetric dimer. J Biol Chem 288:22758–22767
Milacic V, Banerjee S, Landis-Piwowar KR, Sarkar FH, Majumdar AP, Dou QP (2008) Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res 68:7283–7292
Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW, Yamamoto N (1999) Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood 93:2360–2368
Nagarajan S, Choo H, Cho Y, Shin KJ, Oh K-S, Lee B, Pae A (2010) IKKbeta inhibitor identification: a multi-filter driven novel scaffold. BMC Bioinform 11:S15
Nautiyal J, Banerjee S, Kanwar SS, Yu Y, Patel BB, Sarkar FH, Majumdar AP (2011) Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells. Int J Cancer 128:951–961
Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, Howells L (1999) Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18:6013–6020
Qiu X, Du Y, Lou B, Zuo Y, Shao W, Huo Y, Huang J, Yu Y, Zhou B, Du J, Fu H, Bu X (2010) Synthesis and identification of new 4-arylidene curcumin analogues as potential anticancer agents targeting nuclear factor-κB signaling pathway. J Med Chem 53:8260–8273
Sarkar FH, Li Y (2003) Soy isoflavones and cancer prevention: clinical science review. Cancer Invest 21:744–757
Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221–234
Sen R, Baltimore D (1986) Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 47:921–928
Shishodia S, Aggarwal BB (2002) Nuclear factor-kappaB activation: a question of life or death. J Biochem Mol Biol 35:28–40
Tyagi C, Grover S, Dhanjal JK, Goyal S, Goyal M, Grover A (2013) Mechanistic insights into mode of action of novel natural cathepsin L inhibitors. BMC Genomics 14:S10
Tyagi C, Gupta A, Goyal G, Dhanjal JK, Grover A (2014) Fragment based group QSAR and molecular dynamics mechanistic studies on arylthioindole derivatives targeting the α-β interfacial site of human tubulin. BMC Genomics 15:S6
Vats C, Dhanjal JK, Goyal S, Bharadvaja N, Grover A (2014) Computational design of novel flavonoid analogues as potential AChE inhibitors: analysis using group-based QSAR, molecular docking and molecular dynamics simulations. Struct Chem. doi:10.1007/s11224-014-0494-3
VLifeMDS: molecular design suite (2010) VLife Sciences Technologies Pvt. Ltd Pune, India
Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8:127–134
Wolanin K, Magalska A, Mosieniak G, Klinger R, McKenna S, Vejda S, Sikora E, Piwocka K (2006) Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells. Mol Cancer Res 4:457–469
Yan Z, Subbaramaiah K, Camilli T, Zhang F, Tanabe T, McCaffrey TA, Dannenberg AJ, Weksler BB (2000) Benzo[a]pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells. Evidence for the involvement of extracellular signal-regulated kinase and NF-kappaB. J Biol Chem 275:4949–4955
Acknowledgments
AG is thankful to Jawaharlal Nehru University for usage of all computational facilities. AG is grateful to University Grants Commission, India for the Faculty Recharge Position.
Conflict of interests
The authors declare that there is no conflict of interests.
Ethical standards
The manuscript does not contain clinical studies or medical data.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patel, K., Tyagi, C., Goyal, S. et al. Curcumin-based IKKβ inhibiting anticancer lead design using novel fragment-based group QSAR modelling. Med Chem Res 24, 2022–2032 (2015). https://doi.org/10.1007/s00044-014-1274-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-014-1274-8